Cumulative clinical experience with MF59-adjuvanted trivalent seasonal influenza vaccine in young children
Objective: To demonstrate the potential of an MF59-adjuvanted inactivated trivalent seasonal influenza vaccine (aIIV3; Fluad™) to improve the immune response in young children, we review the immunogenicity, efficacy, and safety/tolerability of aIIV3 from a comprehensive clinical development program...
Uloženo v:
| Hlavní autoři: | , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Elsevier
2019-08-01
|
| Edice: | International Journal of Infectious Diseases |
| On-line přístup: | http://www.sciencedirect.com/science/article/pii/S1201971219302152 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|